Neffy, the first non-needle treatment for severe allergic reactions, approved by the FDA for adults and children over 66 pounds, addressing fear of injections and providing a crucial option for anaphylaxis treatment.
Epinephrine nasal spray, Neffy, offers a needle-free alternative for those with fear of injections, potentially reducing barriers to timely anaphylaxis treatment according to FDA's division director.
[
Collection
]
[
|
...
]